Related Experiment Video
Updated: Apr 28, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Biomarkers in the Diagnosis of Aspergillosis
Laura Rivera-Agudelo1, Diego H Cáceres2,3,4, Julián C Arango-Rincón1,5
1Grupo de Micología Médica y Experimental, Corporación para Investigaciones Biológicas CIB-UdeA-UPB-UDES, Medellín 050010, Colombia.
Abstract:
Aspergillosis is a group of different invasive and non-invasive diseases affecting the lung and other organs, caused by species of the genus Aspergillus. Additionally, complications associated with treatment and the increasing emergence of antifungal-resistant strains of Aspergillus spp. are high-impact problems. For these reasons, a combined approach of diagnostic tests is necessary to reach an accurate and timely diagnosis. This review aims to describe some biomarkers and their usefulness for the diagnosis of aspergillosis. Among the findings obtained in different studies, the nature, analytical performance and usefulness for diagnosis in different clinical forms of this disease are described. Currently, the main biomarkers used in the diagnosis of Aspergillus disease fall into three categories: membrane components, specific DNA sequences and metabolic products. The detection of biomarkers is one of the most important innovations of recent decades in the field of medical mycology, as it is a diagnostic aid that allows the timely detection of infections and decreases the time of administration of antifungal therapy.
Insights
Accurate diagnosis of aspergillosis requires multiple tests. Biomarkers, including membrane components, DNA, and metabolic products, aid in early detection and treatment of Aspergillus infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
Background:
- Aspergillosis encompasses diverse invasive and non-invasive diseases caused by *Aspergillus* species.
- Treatment complications and rising antifungal resistance in *Aspergillus* present significant challenges.
Purpose of the Study:
- To review biomarkers for diagnosing aspergillosis.
- To assess the utility and performance of various diagnostic biomarkers.
Main Methods:
- Review of existing studies on aspergillosis biomarkers.
- Categorization of biomarkers into membrane components, DNA sequences, and metabolic products.
Main Results:
- Biomarker detection is a key advancement in medical mycology.
- Diagnostic aids enable prompt identification of *Aspergillus* infections.
- Early detection facilitates timely antifungal therapy.
Conclusions:
- Combined diagnostic approaches are essential for accurate aspergillosis diagnosis.
- Biomarkers significantly improve the speed and accuracy of diagnosing *Aspergillus* diseases.
- Biomarker utilization reduces the time to initiate antifungal treatment.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021